Based on its' cash position of $45 million, the share price should be around $.16. With their enormous pipeline and two phase 3 products (see my sticky post) the average analyst target of $1.23/share is extremely conservative. Personally I am not selling until a market cap of $2.5 billion is reached.
News 
Market Data 
Discover 
